Skip to main content

Cancer Biology Ph.D. Program

The Cancer Biology Ph.D. Program—jointly administered by The Wistar Institute and Philadelphia College of Osteopathic Medicine (PCOM) —trains individuals with outstanding potential for a successful academic or industrial career in cancer biology and drug development.

This comprehensive, integrated cancer biology Ph.D. program is centered on the involvement of both Wistar and PCOM’s faculty and provides an inclusive, broad-based graduate educational venue that complements and expands existing opportunities for cancer training in the greater Philadelphia area. Successful candidates will be granted a Ph.D. in cancer biology from the Philadelphia College of Osteopathic Medicine.

This program focuses on cutting-edge strategies to understand the molecular basis of cancer initiation and progression, while also emphasizing the process of drug discovery and therapeutic development. The curriculum equips students to succeed in a multidisciplinary environment as both hypothesis-driven academic cancer researchers and industrial discoverers.


Our multidisciplinary curriculum combines the basic mechanisms of cancer biology with the translational aspects of drug discovery.


For more information about the Cancer Biology Ph.D. Program, please contact:

Kristy Shuda McGuire, Ph.D.
Dean, Biomedical Studies
Associate Professor, Molecular & Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center
The Wistar Institute
3601 Spruce Street
Philadelphia, PA 19104

Italo Tempera, Ph.D.
Associate Director for Cancer Research Career Enhancement, Ellen and Ronald Caplan Cancer Center
3601 Spruce Street
Philadelphia, PA 19104